Impact of latest generation cardiac interventional X-ray equipment on patient image quality and radiation dose for trans-catheter aortic valve implantations by Gislason-Lee, Amber J. et al.








Cite this article as:
Gislason-Lee AJ, Keeble C, Malkin CJ, Egleston D, Bexon J, Kengyelics SM, et al. Impact of latest generation cardiac interventional X-ray
equipment on patient image quality and radiation dose for trans-catheter aortic valve implantations. Br J Radiol 2016; 89: 20160269.
FULL PAPER
Impact of latest generation cardiac interventional X-ray
equipment on patient image quality and radiation dose for
trans-catheter aortic valve implantations
1AMBER J GISLASON-LEE, MSc, 2CLAIRE KEEBLE, PhD, 3CHRISTOPER J MALKIN, MD, MRCP, 1DANIEL EGLESTON, BSc,
1JOSEPHINE BEXON, BSc, 1STEPHEN M KENGYELICS, MSc, 3DANIEL BLACKMAN, MD, MRCP and
1ANDREW G DAVIES, MSc
1Division of Biomedical Imaging, University of Leeds, Leeds, UK
2Division of Epidemiology and Biostatistics, University of Leeds, Leeds, UK
3Department of Cardiology, Leeds General Infirmary, Leeds, UK
Address correspondence to: Mrs Amber J Gislason-Lee
E-mail: a.j.gislason09@members.leeds.ac.uk
Objectives: This study aimed to determine the impact on
radiation dose and image quality of a new cardiac
interventional X-ray system for trans-catheter aortic
valve implantation (TAVI) patients compared to the
previously-used cardiac X-ray system.
Methods: Patient dose and image data were retrospec-
tively collected from a Philips AlluraClarity (new) and
Siemens Axion Artis (reference) X-ray system. Patient
dose area product (DAP) and fluoroscopy duration of 41
patient cases from each X-ray system were compared
using a Wilcoxon test. Ten patient aortograms from each
X-ray system were scored by 32 observers on a continu-
ous scale to assess the clinical image quality at the given
phase of the TAVI procedure. Scores were dichotomised
by acceptability and analysed using a Chi-squared test.
Results: Significant reductions in patient dose
(p,,0.001) were found for the new system with no
significant change in fluoroscopy duration (p50.052);
procedure DAP reduced by 55%, fluoroscopy DAP by
48% and “cine” acquisition DAP by 61%. There was no
significant difference between image quality scores of
the two X-ray systems (p50.06).
Conclusions: The new cardiac X-ray system demon-
strated a very significant reduction in patient dose with
no loss of clinical image quality.
Advances in Knowledge: The huge growth of TAVI may
impact on the radiation exposure of cardiac patients and
particularly on operators including anaesthetists; cumu-
lative exposure of interventional cardiologists performing
high volume TAVI over 30-40 years may be harmful. The
Phillips Clarity upgrade including improved image en-
hancement and optimised X-ray settings significantly
reduced radiation without reducing clinically acceptable
image quality.
INTRODUCTION
Transcatheter aortic valve implantation (TAVI) is a treat-
ment for patients with symptomatic aortic stenosis, who
are high risk for conventional surgical aortic valve re-
placement. Cardiac interventional X-ray imaging systems
allow for visualization of moving anatomy and interven-
tional equipment in real time—which is essential for TAVI.
High-quality contrast-enhanced image sequences are cap-
tured in acquisition mode for diagnosis and treatment
checks, using an iodine-based agent delivered through
a catheter. Neither the native valve nor the aorta can be
visualized without a contrast agent. The contrast injections
are also required to assess valve competence; a leaking or
incompetent valve may require repositioning or further
expansion. Fluoroscopy mode uses a lower quality X-ray
imaging technique to aid cardiologists to navigate
through the anatomy and to guide valve positioning
and deployment.
During TAVI, X-ray image quality must be sufﬁcient to
enable visualization of individual struts of the prostheses
and their relation to the patient anatomy. Some second-
generation valves have speciﬁc locking and release mech-
anisms, as shown in Figure 1. Very high spatial resolution is
required in order for interventional cardiologists to visu-
alize these TAVI-speciﬁc details. Image frames within a se-
quence must be acquired at high enough rates to enable
temporal resolution that is required for a given phase of the
procedure. Image quality is related to the amount of ra-
diation used to capture the image. For a quantum-limited
X-ray system, the signal-to-noise ratio, a technical mea-
surement of image quality, is proportional to the square
root of the X-ray dose used to create the image;1 to double the
signal-to-noise ratio, the dose must be increased by four times.
Exposure to X-rays can be harmful, and radiation doses from
cardiac interventional procedures are the highest of any routine
medical procedure.2,3 Those from TAVI are reportedly the
highest of the interventional procedure radiation doses.4 Two
types of biological damage may occur from radiation exposure.
Deterministic effects include anatomic damage known to occur
when radiation dose exceeds a speciﬁc amount, such as skin
burns and hair loss on patients undergoing cardiac interven-
tional procedures5–7 and cataracts to the eye lens on interven-
tional cardiologists;8 recently, the cataracts threshold dose was
reduced by 75%,9 prompting efforts to reduce radiation doses to
the eye.10 Stochastic effects, including damage to the DNAwhich
may cause long-term genetic defects and cancers, increase with
radiation exposure; there is no speciﬁc threshold dose and risk is
cumulative, so several decades may pass before manifestation.11
Continuous evolution of TAVI technology and worldwide ac-
ceptance of the efﬁcacy of the procedure12–14 have translated to
more procedures in all subsets of patients. In the UK, the ﬁrst
TAVI case was performed in 2007 with 66 additional procedures
in 4 centres in that year, whereas in 2014, there were 1860 cases
performed in 34 centres.15 Furthermore, increasingly complex
cases are undertaken with the use of alternative access routes,
second-generation valves, cerebral protection devices and “valve
in valve” for failed surgical bioprostheses now becoming stan-
dard practice. An ageing population with a high prevalence of
aortic stenosis, many of whom are unsuitable for open surgery,
suggests that use of TAVI will continue to increase. In Germany,
TAVI has now overtaken surgical valve replacement as the most
frequently used treatment for aortic stenosis.16
Cardiac X-ray system settings should therefore be optimized to
minimize radiation dose whilst maintaining the required level of
image quality for the speciﬁc patient size and clinical task, as
enforced by the “as low as reasonably practicable” principle. It
has been suggested speciﬁcally for cardiac X-ray imaging that
image quality is at times higher than is required for the clinical
task,17–19 causing unnecessarily high levels of radiation dose to
both patients and personnel. In 2018, new legal requirements for
lower radiation exposure limits will be implemented in the UK/
European Union via a new radiation protection directive.20
Recent studies indicate that digital image enhancement has the
potential to help allow for lower radiation doses to be used for
TAVI procedures.21–25 The role of image enhancement has
played an increasingly signiﬁcant role in diagnostic radiology in
the past decade; in real-time cardiac X-ray imaging, increased
computing power is particularly beneﬁcial, as more complex,
adaptive (to image content) enhancement algorithms can be
implemented in clinical practice. Each manufacturer has its own
unique algorithms which enhance images in real time, with task-
speciﬁc enhancement allowing for visualization of clinically
relevant anatomy.
Philips Healthcare’s most recent interventional X-ray system,
AlluraClarity (Philips Healthcare, Eindhoven, Netherlands), has
ClarityIQ image enhancement with real-time image noise re-
duction algorithms which, in combination with anatomy-
speciﬁc X-ray optimization, promise to reduce patient dose.26
With this option, both the radiographic settings used to capture
images and the computer image processing applied to the
images, are different to the previous generation equipment by
the manufacturer. This system has allowed for reduced dose in
neuroradiology27,28 and other digital subtraction angiography
applications,29 percutaneous coronary interventional21–23,30 and
electrophysiology procedures.25 The reduction in dose in TAVI
procedures and, moreover an investigation of corresponding
changes in clinical image quality for patients undergoing TAVI,
has yet to be published. Such a comprehensive assessment of
both radiation dose and image quality is crucial in establishing
a thorough understanding of the clinical impact of a new X-ray
system for this particular clinical application.
An AlluraClarity (Clarity) system was installed at Yorkshire
Heart Centre, Leeds, UK, where six cardiac catheter labs are in
clinical operation. The Clarity lab immediately became the
preferred lab for TAVI procedures owing to the manufacturer
claims of lower doses from this new X-ray system; initial pro-
cedure dose–area product (DAP) observations seemed lower
Figure 1. In the left image, a small gap between the buckle and post is seen; the valve cannot be released because it is not locked. In
the right image, there is no gap between the buckle and post: the valve can be released because it is locked.
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than were reported in the previously preferred lab for TAVI
procedures. For this reason, as well as the rise in the number of
TAVI procedures at Yorkshire Heart Centre, TAVI procedures
were investigated. There were 142 TAVI procedures in 2014 at
Yorkshire Heart Centre,15 more than at any other UK hospital.
This study’s primary aims were to investigate whether the Clarity
system did indeed reduce X-ray dose to patients in TAVI and
whether the image quality remained at a clinically acceptable
level for TAVI with respect to the previously preferred equip-
ment. The study’s secondary aims were to assess the dose re-
duction in ﬂuoroscopy and acquisition modes separately and to
investigate whether there was any alteration in ﬂuoroscopy
duration.
METHODS AND MATERIALS
There were two key components to this study—an assessment
of radiation dose and an assessment of image quality. Both
components were completed in two phases—a pilot experi-
ment to provide data for power calculations and the main
investigation. Two of the six cardiac catheter labs in Yorkshire
Heart Centre were included in the study—the new Philips
AlluraClarity FD10 lab which commenced use in January 2014
and an Axiom Artis (Siemens Healthcare, Erlangen, Germany)
which had been in use since 2007, as the reference lab for
comparison. Details on the novel Philips Clarity settings can be
found in manufacturer-provided documentation available on
the company website.31
This observational study collected data from computer records
of patient doses from the hospital information technology sys-
tems, and as reported by the imaging systems; images were
collected from the picture archiving and communication system
(PACS). Practitioners were not aware of the study and so per-
formed the implantation as per typical practice. Both labs were
generally fully booked for clinical use. All data were anonymized
by removing personally identiﬁable information.
Radiation dose
Procedure DAPs from 58 TAVI procedures completed in the
reference lab were used to power the main dose study for a 30%
difference in procedure DAP with 90% power and 5%
signiﬁcance.
Total procedure DAP as well as acquisition and ﬂuoroscopy DAP
and ﬂuoroscopy duration were recorded for 41 patients un-
dergoing TAVI from each lab; for the new lab, data were
obtained from the ﬁrst 6 months of 2014 and for the reference
lab, data were obtained from the last 6 months of 2013 (before
the procedures moved to the new lab). Median values from the
two labs were compared using a Wilcoxon test.
Image quality
Image sequences from randomly selected TAVI patient proce-
dures from the new and reference labs were collected and digital
imaging and communications in medicine (DICOM) headers
were extracted for relevant metadata. Aortograms from each lab
were randomly selected from this database until 10 which in-
cluded all stages of the TAVI (setup shots, partial deployment,
full deployment) were collected. Image sequences were acquired
at 15 frames per second; only 1 image sequence was chosen from
any given patient. The body mass indices of the patients ranged
from 20 to 40 kg m22 with a median of 27 kg m22 for the
reference lab and 24–33 kg m22 with a median of 26 kg m22 for
the new lab. Contrast volume per aortogram was always
15–20ml at 20ml per second using a power injector.
The two groups of aortograms were scored on a continuous
scale in a blind observer study. The two end points were “un-
satisfactory” (0) and “exceeds requirements” (1), with mid-point
“acceptable” (0.5). Observers were asked to focus on overall level
of diagnostic image quality, answering the question “How good
is the quality of the image for assessing the aortic stenosis or
other clinically relevant image data at this phase of the pro-
cedure?” by clicking anywhere on the continuous scale, as shown
in Figure 2. The use of a continuous scale allowed for ﬂexibility
in the observer response and helped avoid issues associated with
ordinal scales.32 All aortograms were 5123 512 pixels at 8-bit
depth, displayed at 15 frames per second. Bespoke software with
a graphical user interface was designed in MATLAB 2013b
(Mathworks Inc, Natick, MA) speciﬁcally to execute this ob-
server study. The aortograms were shown to observers in
a random order, which differed for each observer, and they
looped continuously until the observer clicked on the scale;
then, the next aortogram was shown, with no time limits im-
posed. Ratings for each aortogram were automatically translated
Figure 2. A screenshot of the graphical user interface used for this study.
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into quantitative scores between 0 and 1 for statistical analysis;
these quantities were not shown to observers.
A pilot study was conducted to power the image quality study
for a 30% difference in image quality with 80% power and 5%
signiﬁcance; three medical imaging experts with 8, 20 and
25 years’ experience with cardiac X-ray imaging scored the
aortograms as described above. A RadiForce RX340 medical-
grade monitor (EIZO Corporation, Ishikawa, Japan) was used,
approximately 70 cm away from the observer, in a room with
slightly dimmed lighting (as in a radiology reporting room).
The main study was approved by the University of Leeds Re-
search Ethics Committee; recruitment took place in Leeds and
Nottingham National Health Service Trust Hospitals and the
British Cardiovascular Society33 annual cardiology meeting ex-
hibition hall. Clinical professionals with relevant experience with
TAVI images were recruited. Observers were informed of the
purpose of the study, were provided with a participant in-
formation sheet and signed a participant consent form; the
forms were not linked to results, hence the data were anony-
mous. The observers provided only their clinical profession and
number of years’ experience. Observers then each assigned
scores to the 20 images as described above, using an Eonis
MDRC-2224 BL clinical display unit (Barco, Brussels, Belgium);
Leeds participants used a Radiforce RX340 monitor.
The statistical analysis was performed using the statistical soft-
ware R (R Foundation for Statistical Computing, Vienna, Aus-
tria). The observer scores were dichotomized by acceptability,
with scores of 0.5 or higher classed as acceptable; binary scores
were then analyzed using a x2 test. A Pearson’s x2 test was used
to determine whether the clinical specialist status of the
observers impacted on the acceptability ratings. The clinical
professionals who took part in the study were classed as either
TAVI specialist or non-specialist according to whether they
contributed to clinical image reporting.
RESULTS
Radiation dose
The power calculation showed that a minimum of 17 cases from
each group would be required for the radiation dose component
of the study; the 41 cases that were used were in excess of this
minimum requirement. Box plots are shown in Figures 3 and 4
for DAP and ﬂuoroscopy duration, respectively. Median total
patient procedure doses were 4031 and 8930 cGy cm2 from
the new and reference labs, respectively, showing the new lab
to be 55% lower. Median acquisition DAPs were 785 and
2029 cGy cm2 from the new and reference labs, respectively,
showing 61% reduction in the new lab. Fluoroscopy median
DAPs were 3460 and 6588 cGy cm2 from the new and reference
labs, respectively, showing 48% reduction in the new lab. The
Wilcoxon test showed strong statistically signiﬁcant differences
in medians for both ﬂuoroscopy and acquisition patient doses at
the 5% signiﬁcance level (p,, 1025 in both cases). Median
ﬂuoroscopy durations were 19 : 09 and 22 : 30 (minutes : sec-
onds) for the new and reference labs, respectively, showing no
statistically signiﬁcant difference (p5 0.052) between the
two labs.
Image quality
The pilot study showed that a minimum of 28 observers were
required for the main image quality study; 32 observers par-
ticipated in the study. There were six cardiologists, three radi-
ologists, seven radiographers, six medical students training in
radiology or cardiology, three medical physicists and seven
clinical support staff. Their experience ranged from 0–35 years,
with a mean of 9.4 years. Half of the observers were classed as
TAVI specialists and half as non-specialists.
Box plots of the image quality scores are shown in Figure 5;
scores covered the entire range 0–1 when rounded to one dec-
imal point, and 72% scores were classed as acceptable. Median
scores for the new and reference labs were 0.56 and 0.60, re-
spectively. The x2 test showed no signiﬁcant difference between
acceptability scores in the two labs (p5 0.06). The Pearson’s x2
showed no signiﬁcant difference between the image quality
scores of the specialist and non-specialist observer groups in
terms of acceptability (p5 0.87).
DISCUSSION
Given the advantages associated with the reduced dose from the
newer imaging equipment, it is encouraging to see that the
absolute difference in image quality scores was very small (0.04);
this difference was not signiﬁcant at the 5% level, although it
was close to the p-value threshold. Both the dose and image
Figure 3. Box plots of acquisition and fluoroscopy dose. DAP,
dose–area product.
Figure 4. A box plot of fluoroscopy duration.
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quality components of the study were strengthened by statistical
planning, i.e. pilot studies and power calculations.
Since TAVI procedures are relatively new and increasing in fre-
quency, there are relatively few interventional cardiologists who
specialize in this ﬁeld compared with, for example, percutaneous
coronary intervention. Therefore, in order to recruit the large
number of observers required for 80% power in the image
quality study (28), other clinical professionals aside from
interventional cardiologists were recruited—those who had
worked on or observed a number of TAVI cases and understood
the phase of the implant during which each aortogram was
acquired. Half of the observers did not take part in image
reporting as part of their clinical profession; however, their
acceptability ratings of the images were not signiﬁcantly dif-
ferent to the specialist observers. This demonstrates that al-
though recruiting these additional observers is not ideal, it did
not affect the outcome of this study. Moreover, the large
amount of observers who took part in the study (32) repre-
sented a broad range of institutions across the country and
therefore a range of local philosophies on what makes a good
cardiac image. This was beneﬁcial because the observers were
not, as a group, accustomed to one particular X-ray system
more than another.
These results are important for interventional cardiologists who
perform TAVI procedures; changes in X-ray settings which allow
for lower reported DAPs will also allow for lower radiation
exposures to personnel.34 Concern for damaging effects of
radiation from interventional cardiac procedures is typically
directed at patients;35 however, impact on cardiologists is not as
often addressed.36 Eye lens cataracts are common and stochastic
effects from radiation are also becoming a concern for inter-
ventional cardiologists. Cumulative radiation exposure from
a working lifetime has been reportedly high enough to increase
the cardiologist risk of cancer to 51%37,38 from the baseline risk
of 25%. Brain and neck tumours in interventional cardiologists
may be induced by occupational radiation exposure.39,40
Cardiologists may begin clinical practice as young as their early
thirties,41 increasing the risk of cancer during their lifetime.
Females are at slightly higher risk than males,11 and the number
of female cardiologists is rising.41 The Organization for
Occupational Radiation Safety in Interventional Fluoroscopy
was founded by an American cardiovascular surgeon who
pioneered the endovascular approach to surgery, to increase
awareness of this issue; he believed his bilateral lens implants in
both eyes, calciﬁed carotid artery and brain tumour were a result
of being chronically exposed to ionizing radiation whilst
performing these image-guided patient procedures.42 A new
initiative by the British Institute of Radiology43 has responded by
creating an online learning resource for interventional cardiol-
ogists. Later in 2016, it will be mandatory in the UK for them to
learn more about the negative effects of radiation, as radiologists
are expected to do.
This study compared two X-ray cardiac catheter laboratories
very similar in design and operation. The X-ray system in the
reference lab was biplane, a feature never used during TAVI, and
the new lab had large monitors. Nonetheless, the differences in
image quality and dose levels found are mainly from the X-ray
imaging systems within the labs.
Fluoroscopy duration was compared to assure any changes in
dose were from the difference in interventional labs, not from
a difference in X-ray duration (for example, owing to a differ-
ence in case complexity between the two groups). The number
of acquisition image frames was not accurately recorded and
hence was not used; in the hospital database, it was impossible to
differentiate an acquisition sequence from a ﬂuoroscopy se-
quence that was stored as per good radiological practice. Inter-
ventional cardiologists reported that the storage of ﬂuoroscopy
sequences increased after moving the TAVI procedures to the
Clarity lab at Yorkshire Heart Centre.
Some of the image quality assessments took place in the exhi-
bition hall of a conference and therefore, the ambient lighting
was not dimmed as it would be in a radiology reporting room.
However, dimmed lighting is not used in the local cardiac
catheter labs, as reported to be the case elsewhere.43 Moreover,
for each observer, both sets of aortograms were viewed under
the same lighting conditions and therefore, lighting was not
a variable between the image sets.
There have been no past published studies which compared the
Philips Clarity system with the Siemens Axiom Artis in terms of
cardiac interventional patient dose and image quality. Any
similar studies did not pertain to patients undergoing TAVI;
therefore, no comparison can be made.
CONCLUSION
The newly installed AlluraClarity cardiac catheter lab had 55%
lower total patient procedure DAP for patients undergoing TAVI
than the reference lab, which was previously used for TAVI
procedures. Fluoroscopy and digital image acquisition DAPs
were 48% and 61% lower, respectively, with no statistically
signiﬁcant difference in ﬂuoroscopy duration between the two
labs. Moreover, the clinical acceptability of the aortograms ac-
quired on the Clarity system was not affected by the re-
duced dose.
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